obesity-995x60.png
FEATURED ARTICLES
C-Suite Changes Help Biotech Narrow Focus But Maintain Drive To Treat Fatal Neonatal Brain Injury
Newly-appointed leaders at ReAlta Life Sciences discuss their skill sets, their goals for advancing a therapy for hypoxic ischemic encephalopathy (HIE), and how they keep momentum as they strive to help bring this potentially lifesaving therapy to market.
-
![Miro Pastrnak headshot]( "The Rare Trials Summit Wants To Produce More Than Conversation")
The Rare Trials Summit Wants To Produce More Than ConversationThe Rare Trials Summit returns to Boston this September with a mission that extends beyond traditional conference presentations. Through interactive workshops and working groups focused on regulatory guidance and pediatric trials, organizers hope to produce practical solutions that help advance rare disease clinical research.
-
![GettyImages-2176324258-chromatography-glp-1-analysis]( "The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical Research")
The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical ResearchMetabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.
-
![Group of doctors in meeting-GettyImages-2169868459]( "What Controlled Immune Challenges Reveal Before Patient Studies Begin")
What Controlled Immune Challenges Reveal Before Patient Studies BeginControlled immune challenges can reveal target engagement and pharmacology before efficacy is measurable, supporting earlier and more informed development decisions.
SERVICES AND PRODUCTS
Plug in your trial details and see the impact of live data capture on queries, timelines, and source data quality.
Expert Support for Clinical Research and Research Administration
Partner with Univo IRB for the participant-centered service and forward-thinking technology you need to navigate a changing industry and get independent IRB approval, faster.
TruTechnologies: Clinical Trial Execution, Live
TruTechnologies (Tru) is the industry’s first clinical trial execution system, delivering truly real-time visibility into trial execution at the point of care.
And it’s about time.
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
Cardinal Symptom Monitoring for Parkinson's and Huntington's Disease Trials
Continuous, objective tracking of cardinal symptoms in chronic diseases can support a better understanding of disease progression and treatment response.